FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

KOPRAN

33.6
-0.25 (-0.74%)
Updated 03:28 06/07 IST

KOPRAN Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for KOPRAN
Disclaimer
0% Bullish
0% Bearish

KOPRAN Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See KOPRAN Share Price Targets >>

KOPRAN Ratings

Long term KOPRAN rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live KOPRAN message board: Is KOPRAN buy or sell? Should I buy KOPRAN shares? Why are KOPRAN shares falling? Should I invest in KOPRAN stock?

  1. Home
  2. KOPRAN Forum

KOPRAN Share Price Discussion

N
Reputation: 3,757 • Jul 1 4:08 AM
Kopran Consolidated March 2020 Net Sales at Rs 87.38 crore, down 12.37% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 3,757 • Jun 18 8:38 AM
Kopran shares climb 10% after USFDA approves DMF of Atenolol filed by subsidiary
The company can commence supplies of the API Atenolol to the US market, Kopran said in its BSE filing.
Moneycontrol
Like
Reply

KOPRAN : DMF OF ATENOLOL APPROVED BY USFDA
Like
Reply
N
Reputation: 3,757 • Feb 3 5:33 AM
Kopran Standalone December 2019 Net Sales at Rs 54.68 crore, down 11.59% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 3,757 • Aug 8, 2019 12:13 PM
Kopran Consolidated June 2019 Net Sales at Rs 84.15 crore, up 38.98% Y-o-Y
www.moneycontrol.com
Like
Reply
N
Reputation: 3,757 • Aug 8, 2019 12:13 PM
Kopran Standalone June 2019 Net Sales at Rs 37.74 crore, up 36.35% Y-o-Y
moneycontrol.com
Like
Reply
N
Reputation: 3,757 • Jun 13, 2019 1:18 AM
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • KOPRAN - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization238.52
    Enterprise Value289.12
    Price to Earnings50.64
    Price to Book Value1.16
    Return on Capital Employed0.05
    Return on Equity0.02
    Face Value10
    Dividend YieldNA
  • KOPRAN Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 634.634.633.3533.6
    Jul 334.534.532.833.85
    Jul 232.7534.732.4534.35
    Jul 13535.832.132.7
    Jun 3035.636.7534.635.15
  • KOPRAN Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹35.01
    30 Day Moving Average₹32.79
    50 Day Moving Average₹30.12
    100 Day Moving Average₹28.08
    200 Day Moving Average₹29.38
  • KOPRAN - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue153.7181.54-0.15
    Operating Profit8.9517.36-0.48
    Profit Before Tax6.9613.1-0.47
    Net Income4.7112.87-0.63
  • KOPRAN - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds205.75209.52-0.02
    Total Liabilities99.85109.53-0.09
    Total Assets305.6310.47-0.02
  • KOPRAN - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity15.776.481.43
    Cash from Investing Activity-5.21-8.88-0.41
    Cash from Financing Activity-10.712.36-5.54
    Net Cash Flow-0.15-0.042.75
  • KOPRAN - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.020.04
    Return on Equity0.020.06
    Return on Capital Employed0.050.09
  • KOPRAN - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.53
    3 Year CAGR Growth in Operating Profit-0.72
    3 Year CAGR Growth in EBIDTA-0.56
    3 Year CAGR Growth in Net Income-0.7
    3 Yr CAGR Growth - Diluted EPS-0.71
  • KOPRAN - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.39
    5 Year CAGR Growth in Operating Profit-0.74
    5 Year CAGR Growth in EBIDTA-0.53
    5 Year CAGR Growth in Net Income-0.61
    3 Yr CAGR Growth - Diluted EPS-0.65
  • KOPRAN - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 1 4:08 AM
    Kopran Consolidated March 2020 Net Sales at Rs 87.38 crore, down 12.37% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 18 8:38 AM
    Kopran shares climb 10% after USFDA approves DMF of Atenolol filed by subsidiary
    Moneycontrol
    NewsBot
    Feb 3 5:33 AM
    Kopran Standalone December 2019 Net Sales at Rs 54.68 crore, down 11.59% Y-o-Y
    Moneycontrol
    NewsBot
    Aug 8, 2019 12:13 PM
    Kopran Consolidated June 2019 Net Sales at Rs 84.15 crore, up 38.98% Y-o-Y
    www.moneycontrol.com
    NewsBot
    Aug 8, 2019 12:13 PM
    Kopran Standalone June 2019 Net Sales at Rs 37.74 crore, up 36.35% Y-o-Y
    moneycontrol.com
    NewsBot
    Jun 13, 2019 1:18 AM
    NewsBot
    Jan 21, 2019 1:17 AM
    NewsBot
    Jan 21, 2019 1:17 AM
  • KOPRAN - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020